Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve Financial Results (Standalone ....
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has informed the exchanges that its Board of Directors will meet on Friday, August 8, 2025, to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter ended June 30, 2025 (Q1FY26). The company is a Mumbai-based entity listed on both BSE (543998) and NSE (VALIANTLAB). This is a routine compliance filing under SEBI Listing Regulations. The trading window for insiders, which was closed from June 27, 2025, will remain shut until August 10, 2025, covering the pre- and post-results period.
No direct impact on stock price from this filing alone, as it is a standard pre-results announcement. Investors should watch for the actual Q1FY26 numbers on August 8 for revenue, profit, and margin trends. The closed trading window signals that material disclosures are expected shortly.